Similar Articles
191 Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients
192 Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis
193 Endocrine causes of nonalcoholic fatty liver disease
194 Genetic background in nonalcoholic fatty liver disease: A comprehensive review
195 Dimethyl sulfoxide inhibits zymosan-induced intestinal inflammation and barrier dysfunction
196 Pathogenesis of hepatocarcinogenesis in non-cirrhotic nonalcoholic fatty liver disease: Potential mechanistic pathways
197 Local corticosterone production and angiotensin-I converting enzyme shedding in a mouse model of intestinal inflammation
198 Inflammation, oxidative stress and renin angiotensin system in atherosclerosis
199 Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease
200 Burden of nonalcoholic fatty liver disease and advanced fibrosis in a Texas Hispanic community cohort
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA